• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody: Technic

  2026-04-30

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive, specific detection of rabbit primary antibodies in immunofluorescence, flow cytometry, and microscopy workflows where robust fluorescent signal and low background are required. It is not appropriate for applications involving non-rabbit primaries or direct detection without a compatible rabbit antibody.

• Ellagic Acid in Senescence-Targeted Assays: Beyond CK2 Inhib

  2026-04-30

  Explore the advanced role of Ellagic acid as a selective CK2 inhibitor in senescence-targeted assays. This article uniquely bridges machine learning-driven senolytic discovery with practical assay optimization for cancer biology research.

• Lactate Drives Macrophage HMGB1 Modification and Exosomal Re

  2026-04-29

  This study uncovers how lactate directly promotes HMGB1 lactylation and acetylation in macrophages, leading to its exosomal release and contributing to sepsis pathology. By elucidating the underlying signaling mechanisms, it identifies new intervention points for inflammatory signaling pathway research.

• Azathramycin A: Strategic Insights for Tuberculosis Research

  2026-04-29

  This thought-leadership article examines the mechanistic value and translational potential of Azathramycin A, a macrolide antibiotic, for Mycobacterium tuberculosis research. By integrating cutting-edge evidence, competitive analyses, and recommendations for experimental design, it provides actionable guidance for researchers seeking to address antibiotic resistance and optimize in vitro tuberculosis models.

• PD0325901: Advancing MEK Inhibition and TERT Regulation Insi

  2026-04-28

  Explore how PD0325901, a potent MEK inhibitor, enables advanced research into RAS/RAF/MEK/ERK pathway inhibition and TERT regulation. This article uniquely integrates recent APEX2/TERT findings and protocol guidance for oncology and stem cell assays.

• c-Myc tag Peptide: Mechanistic Insights for Next-Gen Immunoa

  2026-04-28

  Explore the scientific foundation and unique advantages of the c-Myc tag Peptide for precise immunoassays. This article delivers advanced mechanistic analysis and practical protocols, offering a deeper perspective on c-Myc Peptide applications in cell signaling and transcription factor studies.

• PD0325901: MEK Inhibitor Workflows for Precision Oncology

  2026-04-27

  PD0325901, a selective MEK inhibitor from APExBIO, empowers researchers to dissect and modulate the RAS/RAF/MEK/ERK pathway with unprecedented specificity. This guide delivers actionable protocol enhancements, troubleshooting insights, and evidence-based strategies for maximizing assay sensitivity and translational impact in cancer research.

• SB 431542: Precision ALK5 Inhibition for TGF-β Pathway Studi

  2026-04-27

  SB 431542 is a benchmark ALK5 inhibitor that enables reproducible disruption of TGF-β signaling in diverse biological contexts. Its selectivity and robust performance make it indispensable for probing cell proliferation, immunomodulation, and regenerative differentiation workflows.

• YTHDF1 Phase Separation Directs SSC Fate via IkB-NF-kB-CCND1

  2026-04-26

  Fang et al. reveal that YTHDF1-driven liquid-liquid phase separation (LLPS) is essential for the direct transdifferentiation of spermatogonial stem cells (SSCs) into neural stem cell-like cells. This process operates by repressing IkBa/b mRNA translation, thereby activating the IkB-NF-kB-CCND1 signaling axis and offering new mechanistic insights into cell fate regulation.

• Erastin: Precision Ferroptosis Inducer for Advanced Cancer R

  2026-04-25

  Erastin stands out as a rigorously validated ferroptosis inducer, enabling researchers to dissect iron-dependent, non-apoptotic cell death with high selectivity for RAS/BRAF-mutant tumor cells. This article bridges experimental workflows, troubleshooting strategies, and new mechanistic insights from landmark studies, positioning Erastin as a cornerstone for reproducible, high-impact cancer biology research.

• Bestatin Hydrochloride: Neuropeptide Circuitry and Tumor Mic

  2026-04-24

  Explore the unique role of Bestatin hydrochloride (Ubenimex) in dissecting neuropeptide-driven signaling and tumor microenvironment modulation. This article delivers a deep, evidence-based analysis that bridges neuroscience and cancer research for advanced assay development.

• RNA Pol II Inhibition Triggers Apoptosis Beyond Transcriptio

  2026-04-24

  Harper et al. (2025) uncover that cell death following RNA polymerase II inhibition is not due to passive mRNA depletion but results from an active, apoptosis-triggering signaling pathway initiated by the loss of hypophosphorylated RNA Pol IIA. This mechanistic insight reframes our understanding of transcriptional inhibition lethality and has implications for interpreting cytotoxic drug effects and designing targeted interventions.

• EZ Cap™ Firefly Luciferase mRNA: Optimized Reporter Workflow

  2026-04-23

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure delivers robust, reproducible bioluminescent signals for gene regulation and mRNA delivery assays. Its advanced chemical design enhances translation and stability, giving researchers a reliable tool for sensitive in vitro and in vivo applications.

• Clozapine N-oxide: Precision Chemogenetics for Circuit Disco

  2026-04-23

  This thought-leadership article dissects the evolving role of Clozapine N-oxide (CNO) in enabling high-resolution, causal interrogation of neuronal circuits. By integrating mechanistic insights from landmark Alzheimer’s research and emerging chemogenetic strategies, we offer strategic guidance for translational scientists aiming to bridge preclinical models with human cognitive phenotypes. The discussion highlights APExBIO’s CNO as a gold-standard actuator, connects recent findings to disease-relevant circuit analysis, and charts a path for next-generation GPCR signaling research.

• Bufuralol Hydrochloride in Next-Gen Organoid Pharmacokinetic

  2026-04-22

  Bufuralol hydrochloride—a non-selective β-adrenergic receptor antagonist—unlocks new dimensions in cardiovascular pharmacology research. This article uniquely dissects its integration into human iPSC-derived intestinal organoids, offering advanced insight for β-adrenergic modulation studies.

16872 records 1/1125 page Next 12345 下5页 Last page